BIB: ProShares Ultra Nasdaq Biotechnology

BIB新闻

• 07:10 U.S. Investor Risk Aversion Returns, Expectations Of Losses Deepen In August
• 09:30 Retail Investors Boost U.S. Equity Buying, Institutions Slow Stock Selling In July
• 10:20 4 Calls For Trump’s Pharmaceutical Tariffs
• 18:19 Trump Threatens Up To 200% Tariffs On Drug Imports. The Market Doesn't Believe Him.
• 08:50 2025 Midyear Outlook - Hope Is Not A Strategy
• 18:32 Who Will Benefit From Deregulation?
• 10:30 The HealthCare Sector: A Look At Sector Earnings Trends
• 05:50 3 Areas Of Focus As U.S. Earnings Strength Continues
• 19:30 Healthcare Sector Checkup As U.S. Looks To Change Regulations
• 17:40 Institutional, Retail Investors Shed $27B In US Stocks In Early April Sell-Off
• 12:30 How Will New Tariffs Impact Your Investment Portfolio In 2025?
• 11:00 The Great Transformation: Riding The Wave Of Change
• 09:40 U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs
• 10:05 Volatility Brings Changes To Market Leadership
• 20:32 How ESG Policies Can Keep The Healthcare Sector Fighting Fit
• 08:20 Gold Rush: The Story Behind January's U.S. Trade Data
• 15:36 Inflection Points: Trying To Reason With High Vol Season
• 07:40 From AI To Infrastructure: The 10 Investment Themes Defining The Next 5 Years
• 16:17 Markets In Motion: Tariffs, Tech And Treasure
• 10:20 Under The Microscope: Looking For Opportunity Among Healthcare's Underperformers
• 06:50 Trump Set To Break WTO Rules With Potential Pharma Tariffs